- Home
- OBIO vs RMAX Comparison
OBIO vs RMAX Comparison
Compare OBIO & RMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- RMAX
- Stock Information
- Founded
- OBIO 2017
- RMAX 1973
- Country
- OBIO United States
- RMAX United States
- Employees
- OBIO N/A
- RMAX N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- RMAX Real Estate
- Sector
- OBIO Health Care
- RMAX Finance
- Exchange
- OBIO Nasdaq
- RMAX Nasdaq
- Market Cap
- OBIO 151.3M
- RMAX 151.5M
- IPO Year
- OBIO N/A
- RMAX 2013
- Fundamental
- Price
- OBIO $2.89
- RMAX $7.26
- Analyst Decision
- OBIO Strong Buy
- RMAX Hold
- Analyst Count
- OBIO 5
- RMAX 2
- Target Price
- OBIO $14.20
- RMAX $9.75
- AVG Volume (30 Days)
- OBIO 193.1K
- RMAX 162.4K
- Earning Date
- OBIO 05-12-2025
- RMAX 05-01-2025
- Dividend Yield
- OBIO N/A
- RMAX N/A
- EPS Growth
- OBIO N/A
- RMAX N/A
- EPS
- OBIO N/A
- RMAX 0.44
- Revenue
- OBIO $2,886,000.00
- RMAX $303,865,000.00
- Revenue This Year
- OBIO $21.38
- RMAX N/A
- Revenue Next Year
- OBIO $31.89
- RMAX $1.59
- P/E Ratio
- OBIO N/A
- RMAX $17.24
- Revenue Growth
- OBIO 30.23
- RMAX N/A
- 52 Week Low
- OBIO $2.37
- RMAX $6.90
- 52 Week High
- OBIO $8.87
- RMAX $14.31
- Technical
- Relative Strength Index (RSI)
- OBIO 48.11
- RMAX 40.38
- Support Level
- OBIO $2.76
- RMAX $7.40
- Resistance Level
- OBIO $3.02
- RMAX $7.63
- Average True Range (ATR)
- OBIO 0.18
- RMAX 0.22
- MACD
- OBIO 0.03
- RMAX -0.01
- Stochastic Oscillator
- OBIO 52.06
- RMAX 14.95
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About RMAX RE/MAX Holdings Inc.
RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.